Investor appetite for Canadian cannabis companies has been insatiable in recent months. As recreational legalization in Canada is just months away, investors are looking to the existing licensed medical marijuana producers as a way to gain exposure to the growth ahead of time.
On October 13th, Health Canada approved B.C.-based Potanicals Green Growers Inc. for its cultivation license. Potanicals' parent company, Benchmark Botanics Inc., was just approved for listing on the CSE and will commence trading tomorrow under the ticker CSE:BBT.
Everything You Need to Know About Benchmark Botanics Inc.
The company will trade under the symbol CSE:BBT.
There are currently 21,174,230 securities issued and outstanding.
There are an additional 200,000 shares reserved for issuance.
The CUSIP for these shares is 081612 10 3, and the ISIN is CA081612 10 3 6.
Benchmark Botanics Inc., through its wholly-owned subsidiary, Potanicals Green Growers Inc., is a licensed producer of medical marijuana under Access to Cannabis for Medical Purposes Regulations.
Potanicals received its producer’s license from Health Canada on October 13, 2017.
The production center is based out of the beautiful Peachland, BC with a corporate office in Richmond, BC, Canada.
The company has more than 400,000 sq. ft. worth of facilities under construction to produce cannabis products, and those on-going facilities will be completed during 2018 to 2019.
The company will be able to produce more than 75,000 kg of high-quality indoor cannabis products annually.
The company utilizes advanced aeroponic growing technologies as well as bare root science cultivation to achieve a competitive product advantage.
More information can be found via the company's website, here.
Be sure to subscribe to one or more of our free e-mail newsletters so that you never miss an important cannabis update. Also, don't forget to connect with The Daily Marijuana Observer via social media on Facebook, Twitter, StockTwits, and Instagram.